The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Measles Attenuated Live Vaccine Market Research Report 2024

Global Measles Attenuated Live Vaccine Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764255

No of Pages : 98

Ask Your Query

Synopsis
Global Measles Attenuated Live Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Measles Attenuated Live Vaccine market research.

Key manufacturers engaged in the Measles Attenuated Live Vaccine industry include Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, Novartis, Bavarian Nordic, Medimmune and Changchun Keygen Biological Products, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Measles Attenuated Live Vaccine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Measles Attenuated Live Vaccine market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Measles Attenuated Live Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Merck
  • Pfizer
  • Serum Institute of India
  • GSK
  • Sanofi-Pasteur
  • Novartis
  • Bavarian Nordic
  • Medimmune
  • Changchun Keygen Biological Products
  • Shanghai Institute of Biological Products
  • Wuhan Institute of Biological Products
  • Lanzhou Institute of Biological Products

Segment by Type

  • Powder
  • Liquid

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Measles Attenuated Live Vaccine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Measles Attenuated Live Vaccine Market Overview
1.1 Product Overview and Scope of Measles Attenuated Live Vaccine
1.2 Measles Attenuated Live Vaccine Segment by Type
1.2.1 Global Measles Attenuated Live Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Measles Attenuated Live Vaccine Segment by Application
1.3.1 Global Measles Attenuated Live Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Measles Attenuated Live Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Attenuated Live Vaccine Revenue 2018-2029
1.4.2 Global Measles Attenuated Live Vaccine Sales 2018-2029
1.4.3 Global Measles Attenuated Live Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Measles Attenuated Live Vaccine Market Competition by Manufacturers
2.1 Global Measles Attenuated Live Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Measles Attenuated Live Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Measles Attenuated Live Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Measles Attenuated Live Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Measles Attenuated Live Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles Attenuated Live Vaccine, Product Type & Application
2.7 Measles Attenuated Live Vaccine Market Competitive Situation and Trends
2.7.1 Measles Attenuated Live Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles Attenuated Live Vaccine Players Market Share by Revenue
2.7.3 Global Measles Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles Attenuated Live Vaccine Retrospective Market Scenario by Region
3.1 Global Measles Attenuated Live Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Measles Attenuated Live Vaccine Global Measles Attenuated Live Vaccine Sales by Region: 2018-2029
3.2.1 Global Measles Attenuated Live Vaccine Sales by Region: 2018-2023
3.2.2 Global Measles Attenuated Live Vaccine Sales by Region: 2024-2029
3.3 Global Measles Attenuated Live Vaccine Global Measles Attenuated Live Vaccine Revenue by Region: 2018-2029
3.3.1 Global Measles Attenuated Live Vaccine Revenue by Region: 2018-2023
3.3.2 Global Measles Attenuated Live Vaccine Revenue by Region: 2024-2029
3.4 North America Measles Attenuated Live Vaccine Market Facts & Figures by Country
3.4.1 North America Measles Attenuated Live Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Measles Attenuated Live Vaccine Sales by Country (2018-2029)
3.4.3 North America Measles Attenuated Live Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles Attenuated Live Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles Attenuated Live Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Measles Attenuated Live Vaccine Sales by Country (2018-2029)
3.5.3 Europe Measles Attenuated Live Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles Attenuated Live Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles Attenuated Live Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Measles Attenuated Live Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Measles Attenuated Live Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Measles Attenuated Live Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles Attenuated Live Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Measles Attenuated Live Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Measles Attenuated Live Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Measles Attenuated Live Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles Attenuated Live Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Measles Attenuated Live Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Measles Attenuated Live Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles Attenuated Live Vaccine Sales by Type (2018-2029)
4.1.1 Global Measles Attenuated Live Vaccine Sales by Type (2018-2023)
4.1.2 Global Measles Attenuated Live Vaccine Sales by Type (2024-2029)
4.1.3 Global Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Measles Attenuated Live Vaccine Revenue by Type (2018-2029)
4.2.1 Global Measles Attenuated Live Vaccine Revenue by Type (2018-2023)
4.2.2 Global Measles Attenuated Live Vaccine Revenue by Type (2024-2029)
4.2.3 Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Measles Attenuated Live Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Measles Attenuated Live Vaccine Sales by Application (2018-2029)
5.1.1 Global Measles Attenuated Live Vaccine Sales by Application (2018-2023)
5.1.2 Global Measles Attenuated Live Vaccine Sales by Application (2024-2029)
5.1.3 Global Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Measles Attenuated Live Vaccine Revenue by Application (2018-2029)
5.2.1 Global Measles Attenuated Live Vaccine Revenue by Application (2018-2023)
5.2.2 Global Measles Attenuated Live Vaccine Revenue by Application (2024-2029)
5.2.3 Global Measles Attenuated Live Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Measles Attenuated Live Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Measles Attenuated Live Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Measles Attenuated Live Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India Measles Attenuated Live Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Measles Attenuated Live Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi-Pasteur
6.5.1 Sanofi-Pasteur Corporation Information
6.5.2 Sanofi-Pasteur Description and Business Overview
6.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolio
6.5.5 Sanofi-Pasteur Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Measles Attenuated Live Vaccine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolio
6.7.5 Bavarian Nordic Recent Developments/Updates
6.8 Medimmune
6.8.1 Medimmune Corporation Information
6.8.2 Medimmune Description and Business Overview
6.8.3 Medimmune Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medimmune Measles Attenuated Live Vaccine Product Portfolio
6.8.5 Medimmune Recent Developments/Updates
6.9 Changchun Keygen Biological Products
6.9.1 Changchun Keygen Biological Products Corporation Information
6.9.2 Changchun Keygen Biological Products Description and Business Overview
6.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolio
6.9.5 Changchun Keygen Biological Products Recent Developments/Updates
6.10 Shanghai Institute of Biological Products
6.10.1 Shanghai Institute of Biological Products Corporation Information
6.10.2 Shanghai Institute of Biological Products Description and Business Overview
6.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolio
6.10.5 Shanghai Institute of Biological Products Recent Developments/Updates
6.11 Wuhan Institute of Biological Products
6.11.1 Wuhan Institute of Biological Products Corporation Information
6.11.2 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Description and Business Overview
6.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolio
6.11.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.12 Lanzhou Institute of Biological Products
6.12.1 Lanzhou Institute of Biological Products Corporation Information
6.12.2 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Description and Business Overview
6.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolio
6.12.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles Attenuated Live Vaccine Industry Chain Analysis
7.2 Measles Attenuated Live Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles Attenuated Live Vaccine Production Mode & Process
7.4 Measles Attenuated Live Vaccine Sales and Marketing
7.4.1 Measles Attenuated Live Vaccine Sales Channels
7.4.2 Measles Attenuated Live Vaccine Distributors
7.5 Measles Attenuated Live Vaccine Customers
8 Measles Attenuated Live Vaccine Market Dynamics
8.1 Measles Attenuated Live Vaccine Industry Trends
8.2 Measles Attenuated Live Vaccine Market Drivers
8.3 Measles Attenuated Live Vaccine Market Challenges
8.4 Measles Attenuated Live Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock